Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on Genetics & Health. Browse all Genetics & Health education

Few genetic regions are linked to as many conditions as HLA-DQ. Part of the major histocompatibility complex on chromosome 6, the HLA-DQ genes shape how your immune system recognizes foreign proteins — and specific variants are among the strongest inherited risk factors known for several autoimmune diseases. Understanding what an HLA-DQ result means, and what it does not, is essential to using that information wisely.

What HLA-DQ is

HLA-DQ is a cell-surface receptor built from two proteins encoded by the HLA-DQA1 and HLA-DQB1 genes. It belongs to the MHC class II system, which presents fragments of proteins to immune T-cells so the body can distinguish self from threat. Because different HLA-DQ variants present different molecular shapes more or less effectively, the version you inherit influences which immune responses are easy to mount — and, sometimes, which self-tissues are mistakenly targeted. These variants are grouped into haplotypes such as HLA-DQ2 and HLA-DQ8.

HLA-DQ2 and HLA-DQ8: celiac disease

The clearest link is celiac disease. Roughly 90 to 95 percent of people with celiac disease carry the HLA-DQ2.5 haplotype (alleles DQA1*05:01 and DQB1*02:01), and most of the remainder carry HLA-DQ8. The tag variant rs2187668 is commonly used to flag DQ2.5. These molecules present gluten-derived peptides to the immune system in a way that can trigger the intestinal damage of celiac disease. Critically, though, about 30 to 40 percent of the general population also carries DQ2 or DQ8 — and only a small fraction of them ever develop celiac disease.

Type 1 diabetes and other associations

HLA-DQ variants also rank among the leading genetic risk factors for type 1 diabetes, with specific DQ2 and DQ8 combinations conferring the highest susceptibility. Related HLA signals, tagged by variants such as rs9275596, have been connected to conditions including autoimmune thyroid disease and inflammatory bowel disease. Because one HLA-DQ genotype can influence several immune-mediated conditions, this region is a recurring theme across autoimmune research.

Why an HLA-DQ variant is not a diagnosis

The most important nuance is the difference between sensitivity and predictive value. HLA-DQ testing is highly sensitive: because nearly all celiac patients carry DQ2 or DQ8, a negative result is very useful for helping a provider rule the condition out. But a positive result has low predictive value on its own — most carriers never develop disease. That is why HLA-DQ typing is used clinically to exclude possibilities, not to confirm a diagnosis, and always alongside symptoms, antibody testing, and provider evaluation.

What genetic insight can and cannot do

HLA-DQ biology is a powerful illustration of genetics as a guide, not a guarantee. The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights across peptide-related biological pathways, offering pathway-level context about your immune and metabolic biology. It is educational context about your biology — not a diagnosis of celiac disease, type 1 diabetes, or any condition, and not a prediction that you will develop one. Any concern about an autoimmune condition should be evaluated by a qualified healthcare provider who can order the appropriate confirmatory testing.

Frequently Asked Questions

What diseases are linked to HLA-DQ?

HLA-DQ variants are linked most strongly to celiac disease and type 1 diabetes, and are associated with autoimmune thyroid disease, inflammatory bowel disease, and narcolepsy. The specific haplotype matters: HLA-DQ2 and HLA-DQ8 carry the highest risk for celiac disease and contribute to type 1 diabetes susceptibility.

If I carry HLA-DQ2 or DQ8, will I get celiac disease?

Almost certainly not from the genotype alone. About 30 to 40 percent of people carry DQ2 or DQ8, yet only around 1 percent develop celiac disease. The variant is necessary but not sufficient; diagnosis requires symptoms, antibody testing, and confirmation by a healthcare provider.

Why is HLA-DQ testing useful if it does not diagnose disease?

Its value lies in ruling conditions out. Because nearly all celiac patients carry DQ2 or DQ8, a negative HLA-DQ result makes celiac disease very unlikely, sparing further workup. A positive result simply keeps the possibility open and prompts appropriate clinical testing.

Can I change my HLA-DQ genotype?

No. Your HLA-DQ genotype is fixed at conception and does not change over your lifetime. What can change is how you and a provider respond to that information — for example, monitoring for related conditions or pursuing confirmatory testing if symptoms appear.

Want pathway-level context on your immune and metabolic genetics? Take the Precision Peptide Genetic Test to see what pathway-level genetic context can add to your conversation with a qualified provider.

Disclaimer: The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.

This article is part of the PlexusDx Education Hub. Browse all Genetics & Health education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.